EuBiologics Co., Ltd. (206650.KQ)
KRW 12130.0
(-3.58%)
KRW 12130.0
(-3.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 32.65 Billion KRW | 46.97% |
| 2022 | 22.22 Billion KRW | 55.87% |
| 2021 | 14.25 Billion KRW | 132.79% |
| 2020 | 6.12 Billion KRW | -67.34% |
| 2019 | 18.75 Billion KRW | 62.52% |
| 2018 | 11.53 Billion KRW | 1743.58% |
| 2017 | -702 Million KRW | 83.87% |
| 2016 | -4.35 Billion KRW | -1119.43% |
| 2015 | -356.89 Million KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 7.52 Billion KRW | -44.02% |
| 2024 Q2 | 3.98 Billion KRW | -45.1% |
| 2023 Q3 | 3.31 Billion KRW | -61.24% |
| 2023 Q2 | 8.55 Billion KRW | 18.85% |
| 2023 FY | 32.65 Billion KRW | 46.97% |
| 2023 Q1 | 7.19 Billion KRW | 40.18% |
| 2023 Q4 | 13.44 Billion KRW | 305.52% |
| 2022 Q1 | 4.02 Billion KRW | 3.55% |
| 2022 FY | 22.22 Billion KRW | 55.87% |
| 2022 Q3 | 5.54 Billion KRW | -26.21% |
| 2022 Q2 | 7.51 Billion KRW | 86.47% |
| 2022 Q4 | 5.13 Billion KRW | -7.41% |
| 2021 Q3 | 5.91 Billion KRW | 93.84% |
| 2021 Q1 | 1.39 Billion KRW | 0.0% |
| 2021 FY | 14.25 Billion KRW | 132.79% |
| 2021 Q2 | 3.05 Billion KRW | 118.34% |
| 2021 Q4 | 3.89 Billion KRW | -34.22% |
| 2020 FY | 6.12 Billion KRW | -67.34% |
| 2019 FY | 18.75 Billion KRW | 62.52% |
| 2018 FY | 11.53 Billion KRW | 1743.58% |
| 2017 FY | -702 Million KRW | 83.87% |
| 2016 FY | -4.35 Billion KRW | -1119.43% |
| 2015 FY | -356.89 Million KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 82.98 Billion KRW | 60.645% |
| CMG Pharmaceutical Co., Ltd. | 43.7 Billion KRW | 25.27% |
| Celltrion Pharm, Inc. | 116.95 Billion KRW | 72.077% |
| Huons Global Co., Ltd. | 417.8 Billion KRW | 92.183% |
| DongKook Pharmaceutical Co., Ltd. | 405.04 Billion KRW | 91.937% |
| Enzychem Lifesciences Corporation | 3.29 Billion KRW | -891.625% |
| Humedix Co., Ltd. | 68.04 Billion KRW | 52.004% |
| Boditech Med Inc. | 76.7 Billion KRW | 57.422% |
| FutureChem Co.,Ltd | 758.27 Million KRW | -4207.046% |
| Huons Co., Ltd. | 285.93 Billion KRW | 88.578% |
| BNC Korea Co., Ltd. | 31.97 Billion KRW | -2.13% |
| AptaBio Therapeutics Inc. | 78.49 Million KRW | -41504.541% |